Grants and Contributions:
Title:
Formulation Development Research Project
Agreement Number:
987501
Agreement Value:
$149,764.00
Agreement Date:
Mar 1, 2022 - Jan 31, 2023
Description:
Formulation development and in-vitro evaluation of herbal formulation in a capsule dosage form with combination of stomach-specific mucoadhesive microspheres and colon targeted polymeric microspheres for effectively easing the gastric condition symptoms like bloating, indigestion, heartburns, nausea and constipation.
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Windsor, Ontario, CA N8X 4L2
Reference Number:
172-2021-2022-Q4-987501
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
807611140
Recipient Type:
For-profit organization
Recipient's Operating Name:
Medicap Laboratories
Recipient's Legal Name:
Zurich Pharma Inc
Federal Riding Name:
Windsor West
Federal Riding Number:
35117
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
3254